Totaligent Reports Near-Zero Cash, Ongoing Going Concern, and Massive Post-Period Dilution
summarizeSummary
Totaligent, Inc. filed its quarterly report, revealing a critically low cash balance of $467, continued zero revenue, and an ongoing going concern warning, compounded by a post-period conversion of preferred stock resulting in a 70% increase in common shares outstanding.
check_boxKey Events
-
Severe Liquidity Crisis
The company reported only $467 in cash as of March 31, 2026, with estimated monthly operating expenses of $100,000 to $200,000, indicating less than a day of cash runway.
-
Ongoing Going Concern Warning
Management reiterated substantial doubt about the company's ability to continue as a going concern due to recurring losses, negative working capital of $2.4 million, and the critical need for additional financing.
-
Massive Post-Period Stock Dilution
After the quarter ended, on April 6, 2026, 148,812 Series D Convertible Preferred Shares converted into 148,812,000 common shares, increasing outstanding common stock by approximately 70%.
-
Continued Zero Revenue
Totaligent reported no revenue for the three months ended March 31, 2026, continuing its strategic shift towards platform development and AI integration, which temporarily reduced its emphasis on revenue-generating activities.
auto_awesomeAnalysis
Totaligent, Inc. is facing an extreme liquidity crisis with only $467 in cash, far below its estimated monthly operating expenses of $100,000 to $200,000. This, combined with continued zero revenue and an reiterated going concern warning, highlights severe financial distress. The situation is compounded by a significant post-period dilution event where preferred stock converted into 148.8 million common shares, increasing outstanding shares by approximately 70%. Delays in key strategic acquisitions and joint ventures further add to the uncertainty surrounding the company's future viability.
At the time of this filing, TGNT was trading at $0.02 on OTC in the Finance sector, with a market capitalization of approximately $4.2M. The 52-week trading range was $0.01 to $0.06. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.